2Jemal A, Siegel R, Ward E, et al. Cancer Statistics 2009[J]. CA Cancer J Clin,2009,59(4) :225 -249.
3Rosty C, Goggins M. Early detection of pancreatic carcinoma [ J]. Hematol Oncol Clin Am,2002,16( 1 ) :37 -52.
4Kokhanenko NIu, Ignashov AM, Varga EV, et al. Role of the tumor markers CA 19-9 and careinoembryonic antigen (CEA) in diagnosis, treatment and prognosis of pancreatic cancer [ J]. Vopr Onko1,2001,47 ( 3 ) :294 - 297.
5Parks RW, Garden OJ. Ensuring early diagnosis in pancreatic cancer [ J ]. Practitioner, 2000,244 ( 1609 ) : 336 - 338.
6I-Iaglund C, Lundin J, Kuusela P, et al. CA 242, a new tumor marker for pancreatic cancer: a comparison with CA 19-9,CA 50 and CEA [J]. Br J Cancer, 1994,70(3) : 487 - 492.
7Ventmcci M, Ubalducci GM, Cipolla A, et al. Serum CA 242:the search for a valid marker of pancreatic cancer [J]. Clin Chem Lab Med,1998,36(3) :179 -184.
8Furuya N, Kawa S, Hasebe O, et al. Comparative study of CA 242 and CA 19-9 in chronic pancreatitis [J]. Br J Cancer, 1996,73 (3) :372 - 376.
9Carpelan M, Louhimo J, Stenman UH, et al. CEA, CA19- 9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers [ J ]. Anti Cancer Res, 2002,22 (4) :2311 -2316.
10Fritz S, Hackert T, Hinz U, et al. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas [ J ]. Br J Surz.2011.98( 1 ) :104 - 109.
